✦ LIBER ✦

In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid β-peptide (1–42)-induced oxidative stress

✍ Scribed by M. Perluigi; G. Joshi; R. Sultana; V. Calabrese; C. De Marco; R. Coccia; D.A. Butterfield

Book ID: 116787556
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 290 KB
Volume: 138
Category: Article
ISSN: 0306-4522
DOI: 10.1016/j.neuroscience.2005.12.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protection against amyloid beta-peptide

Protection against amyloid beta-peptide (1–42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: Implications for Alzheimer's disease

✍ Hafiz Mohmmad Abdul; D. Allan Butterfield 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 165 KB

In vivo protective effects of ferulic ac

In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1–42-induced oxidative stress

✍ Marzia Perluigi; Gururaj Joshi; Rukhsana Sultana; Vittorio Calabrese; Carlo De M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB 👁 1 views

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of amyloid-beta peptide (Abeta), a peptide that as both oligomers and fibrils is believed to play a central role in the development and progress of AD by inducing oxidative stress in brain. Therefore, treatment

In vivo protection of synaptosomes from

In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate

✍ Gururaj Joshi; Rukhsana Sultana; Marzia Perluigi; D. Allan Butterfield 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 454 KB